Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)

Launched by ALCON RESEARCH · Jan 15, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how well a specific type of eye lens, called Clareon Vivity intraocular lenses, works for people with astigmatism. Astigmatism is a common vision problem that can affect how clearly you see at different distances. The study aims to measure how any remaining astigmatism might influence your ability to see well when looking far away, at things in the middle distance, and up close.

To participate, you need to be at least 35 years old and have had the Clareon Vivity lenses placed in both of your eyes for at least four months. You should also be able to read letters on an eye chart clearly. However, if your astigmatism is too severe or you have certain eye conditions or previous eye surgeries, you may not be eligible. If you join the study, you’ll be asked to come to scheduled visits for check-ups to monitor your vision and overall eye health. This trial is currently recruiting participants, and it’s a great opportunity to help improve understanding of how these lenses work.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Able to understand and sign an Institution Review Board-approved informed consent form;
• • Willing and able to attend all scheduled study visits as required by the protocol;
• • Implanted with study IOLs in both eyes at least 4 months prior to study participation;
• • BCDVA of 0 logMAR or better in each eye.
• Exclusion Criteria:
• • Residual astigmatism greater than or equal to 1.00 D;
• • Clinically significant ocular conditions as specified in the protocol;
• • History of ocular surgeries other than limbal relaxing incisions
• • Other protocol-specified exclusion criteria may apply.